-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On December 14, CDE's official website showed that Simcere/Vivoryon Therapeutics' new Alzheimer's disease drug PQ912 was reported for the first time in China
From: CDE official website
Varoglutamstat (PQ912) is an oral small molecule inhibitor of glutamyl peptide cyclase (QPCT)
Varoglutamstat plays a role in the early pathogenesis of the disease by preventing the formation of this toxic variant, so it has the potential to prevent neuronal damage
Neurotoxic amyloid N3pE can trigger AD-related pathological pathways, including Aβ oligomer formation, neuroinflammation, and tau-mediated neurotoxicity
The two products introduced by Simcere during the same period both target N3pE